3 Microdosing Alternatives to Relieve Stress
Although the trend is hot, it’s still largely illegal, so consider incorporating these three stress relievers into your life. They’re free, effective, and legal.
Although the trend is hot, it’s still largely illegal, so consider incorporating these three stress relievers into your life. They’re free, effective, and legal.
This school offers the first accredited American degree focused on the study and therapeutic development of psychedelic compounds and related psychoactive drugs.
What are top 5 catalysts for psychedelic stocks in the second half of 2021? Stay tuned to hear how stocks like MindMed (NASDAQ: MNMD),
(NEO:MMED), Compass Pathways (NASDAQ: CMPS), atai Life Sciences ( NASDAQ: ATAI), Tryp Therapeutics, Cybin and more will affect the psychedelic industry in 2021.
Timestamps:
0:00 – Intro
1:38 – #5: A New Psychedelics ETF (PSIL)
4:57 – #4:California Decriminalizing possession of psychedelics, and Legalising the personal production of Psilocybin
7:30 – #3:The commencement of MANY phase 2a trials
10:16 – #2: MindMed’s Project Lucy phase 2b trial begins
11:47 – #1: Compass Pathways phase 2b trial results released
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Check out our website: thepsychedelicinvestor.com
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
#MindMed #MNMD #PsychedelicStocks
Clinicians are currently using TRIPP to help immerse patients into alternative realities and to support patients’ wellbeing before, during, and after ketamine-assisted therapy.
Study authors write, “Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience.”
Since May 2019, nine cities and the state of Oregon have decriminalized psychedelics. Carlos Plazola has had his hand in nearly all of them.
“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital,” says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.
This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing.
Jessika Lagarde, the co-founder of Women on Psychedelics, explores the negative impacts of psilocybin-fueled spiritual tourism on the Mazatec people in Mexico, and offers ideas for more ethical steps forward.
Although based in Canada, the company is building a clinical network of therapists trained in ketamine-assisted psychotherapy across the United States.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.